Skip to content

Capillary Blood Accuracy

Capillary Blood Accuracy

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06544070
Acronym
CAPYBARA
Enrollment
0
Registered
2024-08-09
Start date
2024-11-04
Completion date
2025-11-03
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.

Interventions

Participants will donate finger-prick blood samples to be tested on the Entia Liberty System. The results will not be used to inform clinical decisions or affect routine clinical care in any way.

Sponsors

Entia Ltd
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years old at the time of study entry * Patients undergoing systemic anti-cancer therapy (SACT) * Patients capable of providing written informed consent * Patients undergoing routine Full Blood Count (FBC) laboratory blood tests as part of the standard of care Additional inclusion criteria: * Phase 1 (Longitudinal, low count data): Neutrophil Count ≤ 1.0 x109/L within 24 hours preceding consenting * Phase 2 (Low count data): Neutrophil Count ≤ 1.5 x109/L within 24 hours preceding consenting

Exclusion criteria

* History or current diagnosis of haematological malignancy * Inadequate use and understanding of the English language, requiring a translator

Design outcomes

Primary

MeasureTime frameDescription
Validity of of the Liberty System for haematological parameters of interest: Hb, WBC, PLT, ANCThrough study completion, up to 8 days per participant.The accuracy of the Liberty System will be measured by comparing the results of finger-prick blood samples that have been analysed using the Liberty System to the results of venous (blood from the arm, port or PICC line) blood samples that have been analysed by a standard laboratory haematology analyser.
Reliability of of the Liberty System for haematological parameters of interest: Hb, WBC, PLT, ANCThrough study completion, up to 8 days per participant.To measure the precision of the Liberty System by comparing the results of finger-prick blood samples that have been analysed by the Liberty System to each other, and to venous (blood from the arm, port or PICC line) blood samples that have been analysed by the Liberty System.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026